NOURIEL NIAMEHR: Open Payments
NPI 1679881346 · RESEDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 49 payments from 7 companies in 2025. Trend: 2023 $1,013 · 2024 $598 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| IBSA Pharma Inc. | 15 | $222 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $191 |
| Collegium Pharmaceutical, Inc. | 15 | $156 |
| Virtus Pharmaceuticals LLC | 3 | $71 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Tonix Medicines, Inc. | 1 | $15 |
Products named: Tirosint, RELISTOR, Belbuca, LEVORPHANOL TARTRATE, JOURNAVX, HYMOVIS, TONMYA, XTAMPZA.
Industry payments across CA — which companies pay providers there.
